Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Schedule of warrant activity (Details)

v3.24.1.u1
Stockholders' Equity - Schedule of warrant activity (Details) - Warrants Activity - $ / shares
 12 Months Ended
Feb. 04, 2024
Jan. 29, 2023
Jan. 30, 2022
Weighted average grant date fair value      
Average exercise price, warrants outstanding, beginning balance (in dollars per share) $ 19.20 $ 19.20 $ 19.07
Average exercise price, warrants issued (in dollars per share) 0 0 0
Average exercise price, expired and canceled (in dollars per share) 0 0 9.83
Average exercise price, exercised (in dollars per share) 19.20 0 16.00
Average exercise price, warrants outstanding, ending balance (in dollars per share) $ 0 $ 19.20 $ 19.20
Number of options      
Number of warrants, outstanding, beginning balance (in shares) 281,750 281,750 293,973
Number of warrants, warrants issued (in shares) 0 0 0
Number of warrants, expired and canceled (in shares) 0 0 (98)
Number of warrants, exercised (in shares) (281,750) 0 (12,125)
Number of warrants, warrants outstanding, ending balance (in shares) 0 281,750 281,750
Weighted average remaining contractual life (in years). warrants outstanding, beginning balance 4 months 28 days 1 year 4 months 28 days 2 years 6 months 25 days
Weighted average remaining contractual life (in years), exercised     1 month 2 days
Weighted average remaining contractual life (in years). warrants outstanding, ending balance   4 months 28 days 1 year 4 months 28 days